Preclinical Spinal Cord Injury Studies
PsychoGenics is at the forefront of preclinical spinal cord injury (SCI) research, and we are dedicated to fostering the development...
Preclinical CNS Services
At PsychoGenics, our pioneering strategies and advanced preclinical testing services deliver the high-quality data you need to make critical go/no-go...
Mark Varney, Ph.D.
Dr. Varney received his Ph.D. and postdoctoral training in pharmacology from Oxford University, U.K. He is chief scientific officer at...
Leslie Street, Ph.D.
Dr. Street received his Ph.D. in organic chemistry from the University of Leeds in the U.K. and then did postdoctoral...
Preclinical Seizure Studies
Our synchronized Video-EEG system allows us to capture both spontaneous and chemical-induced seizure data, providing valuable insights into the impact of...
Emyria Starts Program with Neuroscience Drug Discovery CRO
By Jim Cornall · Sept 22, 2022 · Labiotech.eu Emyria Limited, a clinical stage biotech, is set to work with PsychoGenics,...
Transcriptional Assessment of Striatal mRNAs as Valid Biomarkers of Disease Progression in Three Mouse Models of Huntington’s Disease
DOI: 10.3233/JHD-190389 Afshin Ghavami 1, Michael Olsen 1, Mei Kwan 1, Jose Beltran 1, John Shea 1, Sylvie Ramboz 1, Wenzhen Duan 2, Daniel Lavery 3, David Howland 3, Larry C Park 3 Abstract Background: Huntington’s disease (HD) is a progressive...
Preclinical Anxiety Studies
PsychoGenics consistently delivers high-quality preclinical anxiety studies using a diverse range of models and tests. With advanced technology and expertise,...